Role of C-myb in Hematopoiesis and Cancer
C-myb 在造血和癌症中的作用
基本信息
- 批准号:7629613
- 负责人:
- 金额:$ 37.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAlternative SplicingAnemiaBiologicalBiological ModelsBone MarrowBone Marrow CellsC-terminalCell ProliferationCell SurvivalCell physiologyCellsCompetenceDevelopmentEmbryoErythropoiesisExhibitsExonsGene FamilyGene ProteinsGenesGenetic ModelsGenetic RecombinationGenetic TranscriptionHematopoiesisHematopoieticHematopoietic stem cellsHepaticIL2RA geneImpairmentIn VitroInterferon Type IKnockout MiceLeadLymphoidMYB geneMaintenanceMalignant NeoplasmsMediatingMolecularMolecular AnalysisMouse StrainsMusMutant Strains MiceMyelogenousMyeloid CellsMyeloid LeukemiaMyelopoiesisNamesNuclear ProteinNuclear ProteinsPlayPopulationProtein BindingProtein IsoformsProteinsProteomicsProto-Oncogene Proteins c-mybPublishingRNA SplicingRetroviridaeRoleStagingStem Cell DevelopmentSystemT-Cell DevelopmentT-LymphocyteTissuesTransactivationTransgenic Organismsbaseembryonic stem cellfetalgene functionhematopoietic tissuein uteroin vivoleukemialeukemogenesismembermouse developmentmouse modelmutantmyb Genesprogenitorresearch studyself-renewaltranscriptional coactivator p75tumorigenesis
项目摘要
DESCRIPTION (provided by applicant): It is now well established that the c-myb gene encodes for two proteins, p75-Myb and p89-Myb, and plays a critical role in the development, proliferation and oncogenesis of hematopoietic cells. Because constitutive loss of the c-myb gene leads to embryonic lethality, it has not been possible to accurately assess the role of this gene in the maintenance of adult hematopoiesis. To overcome this problem and to investigate the function of this gene in adult hematopoiesis, we used the Cre-LoxP recombination system to achieve tissue-specific deletion of c-myb. In a recently published study, we have generated two T cell-specific c-myb knockout mouse models mybF/F/LckCre and mybF/F/CD4Cre, which delete c-myb at two specific stages of T cell development. Studies with these mice have allowed us to define the role of c-myb in T cell development and function. In contrast to the function of p75-c-Myb, the role of p89c-Myb in hematopoiesis is not known. To examine the function of the p89c- myb isoform, we have generated a mouse model where exon 9A is deleted, and as a consequence, this mutant mouse is incapable of producing the p89-c-Myb. A role for c-myb in leukemogenesis was established when It was shown that retrovirus-induced mouse myeloid leukemias express a C- terminal truncated form of c-myb (termed t-myb), which exhibits enhanced transactivating and transformation activities. To determine the biological effects of myb gene truncation during mouse development and hematopoiesis, we have generated a strain of mice which express a C-terminal deletional mutant of c-Myb conditionally. In this application, we propose to use these powerful mouse genetic models to determine the roles played by p75 and p89 isoforms of c-Myb in hematopoiesis and the consequence of C-terminal truncation of c-Myb in hematopoiesis and leukemogenesis. The aims are: 1. To ascertain the molecular mechanisms by which c-Myb regulates T-cell development at the DP stage, gene array and proteomics analysis will be performed, and the functions of those altered genes and proteins will be assessed using both in vivo and in vitro conditions. 2. To determine the role of c-myb in adult hematopoiesis and myeloid development. 3. To define the role of c-myb in Hematopoietic Stem Cell (HSC) development and function. 4. To determine the roles of an alternatively spliced form of c-myb, the p89c-myb, and a genetically truncated version of c-myb, t- myb, in lineage commitment, proliferation and survival of myeloid progenitors and HSCs; and 5. To examine the role of c-myb in BCRABL-mediated transformation of myeloid cells.
描述(由申请人提供):现在已经很好地确定,C-MYB基因编码两种蛋白质P75-MYB和P89-MYB,并且在造血细胞的发育,增殖和发作中起着至关重要的作用。由于c-MYB基因的构型丧失会导致胚胎致死性,因此无法准确评估该基因在维持成年造血的作用。为了克服这个问题并研究该基因在成年造血中的功能,我们使用CRE-LoxP重组系统实现了C-MYB的组织特异性缺失。在最近发表的一项研究中,我们已经生成了两个T细胞特异性的C-MYB敲除小鼠模型MYBF/F/LCKCRE和MYBF/F/CD4CRE,它们在T细胞开发的两个特定阶段删除C-MYB。对这些小鼠的研究使我们能够定义C-MYB在T细胞发育和功能中的作用。与p75-c-myb的功能相反,尚不清楚p89c-myb在造血中的作用。为了检查p89c- myb同工型的功能,我们生成了一个小鼠模型,其中删除了外显子9a,因此,该突变小鼠无法产生p89-c-myb。当表明逆转录病毒诱导的小鼠髓样白血病表达c-Myb(称为T-MYB)的C-末端截断形式(称为T-MYB)时,C-MYB在白血病发生中的作用,该作用表现出增强的反式激活和转化活性。为了确定小鼠发育和造血过程中Myb基因截断的生物学作用,我们产生了一小鼠,该菌株有条件地表达了C-MYB的C末端缺失突变体。在此应用中,我们建议使用这些强大的小鼠遗传模型来确定C-MYB在造血中的P75和P89同工型的作用,以及C-MYB在造血和白血病发生中C末端截断的结果。目的是:1。要确定C-MYB在DP阶段调节T细胞发育的分子机制,将进行基因阵列和蛋白质组学分析,并且将使用体内和体外条件来评估这些改变的基因和蛋白质的功能。 2。确定C-MYB在成年造血和髓样发育中的作用。 3。定义C-MYB在造血干细胞(HSC)发育和功能中的作用。 4。确定C-MYB的剪接形式的作用,P89C-MYB以及C-Myb,T-MYB的遗传截断版本在谱系承诺,髓样祖细胞和HSC的谱系承诺,增殖和存活中; 5。检查c-Myb在BCRABL介导的髓样细胞转化中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E Premkumar Reddy其他文献
E Premkumar Reddy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E Premkumar Reddy', 18)}}的其他基金
Targeting FL3 and SRC kinases for AML therapy
靶向 FL3 和 SRC 激酶进行 AML 治疗
- 批准号:
10658259 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Targeting cell cycle and metabolic pathways of high risk breast cancers using mouse models of hyperinsulinemia
使用高胰岛素血症小鼠模型靶向高风险乳腺癌的细胞周期和代谢途径
- 批准号:
10671005 - 财政年份:2020
- 资助金额:
$ 37.5万 - 项目类别:
Targeting cell cycle and metabolic pathways of high risk breast cancers using mouse models of hyperinsulinemia
使用高胰岛素血症小鼠模型靶向高风险乳腺癌的细胞周期和代谢途径
- 批准号:
10199970 - 财政年份:2020
- 资助金额:
$ 37.5万 - 项目类别:
Targeting cell cycle and metabolic pathways of high risk breast cancers using mouse models of hyperinsulinemia
使用高胰岛素血症小鼠模型靶向高风险乳腺癌的细胞周期和代谢途径
- 批准号:
10029076 - 财政年份:2020
- 资助金额:
$ 37.5万 - 项目类别:
Targeting cell cycle and metabolic pathways of high risk breast cancers using mouse models of hyperinsulinemia
使用高胰岛素血症小鼠模型靶向高风险乳腺癌的细胞周期和代谢途径
- 批准号:
10457279 - 财政年份:2020
- 资助金额:
$ 37.5万 - 项目类别:
Targeting CDK4 in TGS-B Inactivated Gastrointestinal Cancers
TGS-B 灭活胃肠道癌中靶向 CDK4
- 批准号:
8744873 - 财政年份:2013
- 资助金额:
$ 37.5万 - 项目类别:
Targeting Mitotic Kinases Inhibitors for Cancer Therapy
靶向有丝分裂激酶抑制剂用于癌症治疗
- 批准号:
8985660 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Targeting Mitotic Kinases Inhibitors for Cancer Therapy
靶向有丝分裂激酶抑制剂用于癌症治疗
- 批准号:
8787991 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Targeting Mitotic Kinases Inhibitors for Cancer Therapy
靶向有丝分裂激酶抑制剂用于癌症治疗
- 批准号:
8435360 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
Targeting Mitotic Kinases Inhibitors for Cancer Therapy
靶向有丝分裂激酶抑制剂用于癌症治疗
- 批准号:
8238575 - 财政年份:2012
- 资助金额:
$ 37.5万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Integrating Epidemiologic and Genomic Data to Elucidate the Genetic Overlap Between Congenital Anomalies and Pediatric Cancer
整合流行病学和基因组数据来阐明先天性异常和儿童癌症之间的遗传重叠
- 批准号:
10749761 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
BIN1-interactome in Alzheimer's disease pathophysiology
BIN1-相互作用组在阿尔茨海默病病理生理学中的作用
- 批准号:
10677190 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Function of RUNX1 in diverse Down syndrome tissues
RUNX1在多种唐氏综合症组织中的功能
- 批准号:
10853906 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Role of m6A RNA modifications in AHR-mediated developmental toxicity
m6A RNA 修饰在 AHR 介导的发育毒性中的作用
- 批准号:
10647294 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别: